PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Agents that target viral RNA could be the basis for next generation anti-viral drugs

2021-05-10
(Press-News.org) A new approach to tackling viruses by targeting the 'control centre' in viral RNA could lead to broad spectrum anti-viral drugs and provide a first line of defence against future pandemics, according to new research at the University of Birmingham.

In a new study, published in Angewandte Chemie, researchers have shown how this approach could be effective against the SARS-CoV-2 virus responsible for the COVID-19 pandemic. Earlier modelling and in vitro analysis by the team and published in Chemical Science has also shown effectiveness against the HIV virus.

Professor Mike Hannon, from the University of Birmingham's School of Chemistry, is co-lead author of the study. He said: "Although SARS-CoV-2 vaccines have been developed with unprecedented speed, there has still been a 12-month wait for development and approval. Viral pandemics remain a big threat and so broad-spectrum anti-virals are urgently needed to keep diseases like coronaviruses at bay while effective drugs are developed."

The technique proposed by the team uses cylindrically-shaped molecules which can block the function of a particular section at one end of the RNA strand. These RNA sections, known as untranslated RNA, are essential for regulating the replication of the virus.

Untranslated RNA contain junction points and bulges - essentially small holes in the structure- which are normally recognised by proteins or other pieces of RNA - events that are critical for viral replication to occur. The cylindrical molecules are attracted to these holes, and once they slide into them, the RNA closes around them, forming a precise fit, which consequently will interfere with the virus's ability to replicate.

"Our approach offers a very promising new route for anti-viral drug design," says Professor Hannon. "While most drugs in development target the virus's proteins, we have identified molecules capable of tackling the most fundamental part of the virus - its RNA. Experiments backed up by computer modelling have already shown this to be effective against SARS-CoV-2 and the HIV viruses and we anticipate it will also be effective against a wide range of other viruses, offering an important first step towards a broad spectrum anti-viral drug."

Co-lead author Dr Pawel Grzechnik, of the University of Birmingham's School of Biosciences, said: "The ongoing COVID-19 pandemic has revealed how important is RNA biology to understand molecular processes taking place in our cells, to find ways to suppress pathogens and to make efficient and safe vaccines. RNA only now emerges in the general consciousness of society as the major tool in therapies. We hope to continue our research and further investigate antiviral properties of the cylinders at the University of Birmingham."

Dr Zania Stamataki, of the University of Birmingham's Institute of Immunology and Immunotherapy and also co-lead author, said: "The SARS-CoV-2 pandemic has stressed the pressing need for the development on new antiviral treatments, particularly for RNA viruses. In Birmingham we have state-of-the-art containment level 3 facilities that allow us to study the full virus life cycle. We have developed models to test the effects of new antiviral therapies, and the supramolecular cylinders show promising results against replicating SARS-CoV-2. The ambition is that these new categories of compounds can be refined and targeted to extend their function against many other viruses that infect humans and animals."

The team will continue to develop the design of the cylindrical molecule to improve its effectiveness and control, and also to fully understand how it works within the virus before testing it in a model organism.

The research was funded by the Engineering and Physical Sciences Research Council, the Biotechnology and Biological Sciences Research Council (both part of UK Research and Innovation), the Wellcome Trust, the Royal Society, the Medical Research Foundation and the EU Marie Curie Fellowship scheme.

The cylindrical molecules have been the subject of previous research, led by Professor Hannon, which focussed on finding a way to control the way the cylinder interacts with DNA and RNA. This research resulted in novel compounds that have the potential to be developed into targeted treatments for cancers, viruses and other diseases, and is the subject of a patent application filed by University of Birmingham Enterprise.

INFORMATION:

Notes to editor:

* The University of Birmingham is ranked amongst the world's top 100 institutions. Its work brings people from across the world to Birmingham, including researchers, teachers and more than 6,500 international students from over 150 countries.



ELSE PRESS RELEASES FROM THIS DATE:

Friendly pelicans breed better

Friendly pelicans breed better
2021-05-10
Captive pelicans that are free to choose their own friendships are more likely to breed successfully on repeated occasions, new research suggests. Social network analysis on captive great white pelicans, led by the University of Exeter, found that providing social choice within the flock and allowing partnerships to form naturally led to improved breeding success. The study revealed that the pelicans chose their specific social relationships, and that there was a social structure across the flock, in which sub-adults (the equivalent of teenagers) spent more time with each other than with adult birds. Zoo-housed pelicans are common, but their breeding record is poor and they receive little ...

SARS-CoV-2 research: Second possible effective mechanism of remdesivir discovered

2021-05-10
FRANKFURT. The virostatic agent remdesivir was developed to disrupt an important step in the propagation of RNA viruses, to which SARS-CoV-2 also belongs: the reproduction of the virus's own genetic material. This is present as RNA matrices with which the host cell directly produces virus proteins. To accelerate the production of its own proteins, however, RNA viruses cause the RNA matrices to be copied. To do so, they use a specific protein of their own (an RNA polymerase), which is blocked by remdesivir. Strictly speaking, remdesivir does not do this itself, but rather a substance that is synthesized from remdesivir in five steps when remdesivir penetrates a cell. In ...

Dartmouth-led study finds overemphasis on toy giveaways in TV ads unfairly promotes fast-food to children

2021-05-10
A new Dartmouth-led study, published this week in the journal Pediatrics, has found that the disproportionate use of premiums within child-targeted TV advertising for children's fast-food meals is deceptive. The researchers examined thousands of advertisements from 11 fast-food restaurants, but one company--McDonald's--accounted for nearly all the airtime and, as a result, the findings. The researchers report that these ads often overemphasize premiums such as toy giveaways and games relative to the primary product being sold, the fast food itself. This marketing practice violates the industry's own guidelines--put in place to ensure that the use of premiums in ads is not deceptive or unfair--as young children lack the cognitive ability ...

Synergistic effects of acoustics-based therapy and immunotherapy in cancer treatment

2021-05-10
Announcing a new article publication for BIO Integration journal. In this review the authors Yuheng Bao, Jifan Chen, Pintong Huang and Weijun Tong from Zhejiang University, Hangzhou, China discuss the synergistic effects of acoustics-based therapy and immunotherapy in cancer treatment. Cancer immunotherapy to enhance the autogenous immune response to cancer tissue is reported to be a promising method for cancer treatment. After the release of damage-associated molecular patterns, dendritic cells mature and recruit activated T cells to induce immune response. To trigger the release of cancer associated antigens, cancer acoustics-based therapy has various prominent advantages and has been reported in various research. ...

Research shows opportunities to improve the accuracy of dispatching pre-hospital critical care

2021-05-10
In a retrospective study of trauma patients over 65 years of age attended by KSS, it was found that, although a number of these patients had sustained a minor injury through seemingly innocuous mechanisms, a high proportion of this group required advanced clinical interventions and subsequent tertiary level care at a major trauma centre. The study also identified that dispatch time to these patients was typically longer, in particular in instances when KSS's critical care was requested by an ambulance crew already in attendance. With response time often critical to patient outcomes, the ...

Fifty shades of reading: Who reads contemporary erotic novels and why?

2021-05-10
Soon after E.L. James's Fifty Shades of Grey appeared in 2015, the book market was inundated with a flood of erotic bestsellers. People from all corners began wondering what this type of novel's secret of success could be. Now, a research team at the Max Planck Institute for Empirical Aesthetics (MPIEA) in Frankfurt/Main, Germany, has taken a closer look at the readership of erotic novels and investigated the causes of this literary predilection. In the media as well as the academy, contemporary erotica is typically dismissed as being of low literary value. Critics and scholars tend to classify its readers as having mediocre to poor taste, without, however, examining ...

Even small bills for health insurance may cause healthy low-income people to drop coverage

2021-05-10
Twenty dollars a month might not seem like a lot to pay for health insurance. But for people getting by on $15,000 a year, it's enough to make some drop their coverage - especially if they're healthy, a new study of Medicaid expansion participants in Michigan finds. That could keep them from getting preventive or timely care, and could leave their insurance company with a sicker pool of patients than before, say the researchers from the University of Michigan and University of Illinois Chicago. They have published their findings as a working paper through the National Bureau of Economic Research, ahead of publication in the American Journal of Health Economics. The study has implications for other states that require ...

New vaccine blocks COVID-19 and variants, plus other coronaviruses

2021-05-10
DURHAM, N.C. - A potential new vaccine developed by members of the Duke Human Vaccine Institute has proven effective in protecting monkeys and mice from a variety of coronavirus infections -- including SARS-CoV-2 as well as the original SARS-CoV-1 and related bat coronaviruses that could potentially cause the next pandemic. The new vaccine, called a pan-coronavirus vaccine, triggers neutralizing antibodies via a nanoparticle. The nanoparticle is composed of the coronavirus part that allows it to bind to the body's cell receptors and is formulated with a chemical booster called an adjuvant. ...

Clue to killer whale cluster

Clue to killer whale cluster
2021-05-10
A Flinders University researcher has finally fathomed why large numbers of killer whales gather at a single main location off the Western Australian southern coastline every summer. In a new paper published in Deep Sea Research, physical oceanographer Associate Professor Jochen Kampf describes the conditions which have produced this ecological natural wonder of orcas migrating to the continental slope near Bremer Bay in the western Great Australian Bight from late austral spring to early autumn (January-April). "The aggregation is connected to the local marine food web that follows from the upwelling of benthic particulate organic matter (POM) ...

Brain cancer breakthrough provides hope for new treatments

Brain cancer breakthrough provides hope for new treatments
2021-05-10
A novel approach to immunotherapy design could pave the way for new treatments for people with an aggressive form of brain cancer called glioblastoma. Using specifically designed receptors, researchers were able to completely clear brain cancer tumours in preclinical models, using chimeric antigen receptor (CAR) T cell therapy. Published today in Clinical & Translational Immunology and led by Associate Professor Misty Jenkins, the research is a crucial step towards developing new immunotherapy treatments for this devastating illness. More than 1800 Australians are diagnosed with brain cancer every year. ...

LAST 30 PRESS RELEASES:

Interpreting population mean treatment effects in the Kansas City Cardiomyopathy Questionnaire

Targeting carbohydrate metabolism in colorectal cancer: Synergy of therapies

Stress makes mice’s memories less specific

Research finds no significant negative impact of repealing a Depression-era law allowing companies to pay workers with disabilities below minimum wage

Resilience index needed to keep us within planet’s ‘safe operating space’

How stress is fundamentally changing our memories

Time in nature benefits children with mental health difficulties: study

In vitro model enables study of age-specific responses to COVID mRNA vaccines

Sitting too long can harm heart health, even for active people

International cancer organizations present collaborative work during oncology event in China

One or many? Exploring the population groups of the largest animal on Earth

ETRI-F&U Credit Information Co., Ltd., opens a new path for AI-based professional consultation

New evidence links gut microbiome to chronic disease outcomes

Family Heart Foundation appoints Dr. Seth Baum as Chairman of the Board of Directors

New route to ‘quantum spin liquid’ materials discovered for first time

Chang’e-6 basalts offer insights on lunar farside volcanism

Chang’e-6 lunar samples reveal 2.83-billion-year-old basalt with depleted mantle source

Zinc deficiency promotes Acinetobacter lung infection: study

How optogenetics can put the brakes on epilepsy seizures

Children exposed to antiseizure meds during pregnancy face neurodevelopmental risks, Drexel study finds

Adding immunotherapy to neoadjuvant chemoradiation may improve outcomes in esophageal cancer

Scientists transform blood into regenerative materials, paving the way for personalized, blood-based, 3D-printed implants

Maarja Öpik to take up the position of New Phytologist Editor-in-Chief from January 2025

Mountain lions coexist with outdoor recreationists by taking the night shift

Students who use dating apps take more risks with their sexual health

Breakthrough idea for CCU technology commercialization from 'carbon cycle of the earth'

Keck Hospital of USC earns an ‘A’ Hospital Safety Grade from The Leapfrog Group

Depression research pioneer Dr. Philip Gold maps disease's full-body impact

Rapid growth of global wildland-urban interface associated with wildfire risk, study shows

Generation of rat offspring from ovarian oocytes by Cross-species transplantation

[Press-News.org] Agents that target viral RNA could be the basis for next generation anti-viral drugs